BCPPS Pulmonary Questions with Correct
Answers of the Latest Update 2024/2025
budesonide nebulizer - ✔✔low dose 0.25-0.5 mg
medium dose 0.5-1 mg
high dose >1 mg
budesonide DPI - ✔✔low dose 180-360 mcg
medium dose 360-720 mcg
high dose >720 mcg
fluticasone MDI - ✔✔low dose 88-176 mcg
medium dose 176-352 mcg
high dose >352 mcg
fluticasone DPI - ✔✔low dose 100-200 mcg
medium dose 200-400 mcg
high dose >400 mcg
beclomethasone MDI - ✔✔low dose 80-160 mcg
medium dose 160-320 mcg
high dose >320 mcg
mometasone DPI - ✔✔low dose 110 mcg
medium dose 220-440 mcg
, high dose >440 mcg
intermittent asthma age 0-4 - ✔✔no nighttime awakenings
no effect on normal activity
symptoms <2 days/week
SABA use <2 times/week
treatment: SABA PRN
mild persistent asthma age 0-4 - ✔✔1-2 nighttime awakenings/month
minor effect on normal activity
symptoms >2 days/week
SABA use >2 days/week
treatment: low dose ICS
moderate persistent asthma age 0-4 - ✔✔3-4 nighttime awakenings/month
some effect on normal activity
daily symptoms
daily SABA use
treatment: medium dose ICS
severe persistent asthma age 0-4 - ✔✔>1 nighttime awakening/week
extreme effect on normal activity
symptoms several times/day
SABA use several times/day
treatment: medium dose ICS
Answers of the Latest Update 2024/2025
budesonide nebulizer - ✔✔low dose 0.25-0.5 mg
medium dose 0.5-1 mg
high dose >1 mg
budesonide DPI - ✔✔low dose 180-360 mcg
medium dose 360-720 mcg
high dose >720 mcg
fluticasone MDI - ✔✔low dose 88-176 mcg
medium dose 176-352 mcg
high dose >352 mcg
fluticasone DPI - ✔✔low dose 100-200 mcg
medium dose 200-400 mcg
high dose >400 mcg
beclomethasone MDI - ✔✔low dose 80-160 mcg
medium dose 160-320 mcg
high dose >320 mcg
mometasone DPI - ✔✔low dose 110 mcg
medium dose 220-440 mcg
, high dose >440 mcg
intermittent asthma age 0-4 - ✔✔no nighttime awakenings
no effect on normal activity
symptoms <2 days/week
SABA use <2 times/week
treatment: SABA PRN
mild persistent asthma age 0-4 - ✔✔1-2 nighttime awakenings/month
minor effect on normal activity
symptoms >2 days/week
SABA use >2 days/week
treatment: low dose ICS
moderate persistent asthma age 0-4 - ✔✔3-4 nighttime awakenings/month
some effect on normal activity
daily symptoms
daily SABA use
treatment: medium dose ICS
severe persistent asthma age 0-4 - ✔✔>1 nighttime awakening/week
extreme effect on normal activity
symptoms several times/day
SABA use several times/day
treatment: medium dose ICS